EFFECT OF PROPHYLACTIC EPSILON-AMINOCAPROIC ACID ON BLOOD-LOSS AND TRANSFUSION REQUIREMENTS IN PATIENTS UNDERGOING FIRST-TIME CORONARY-ARTERY BYPASS-GRAFTING - A RANDOMIZED, PROSPECTIVE, DOUBLE-BLIND-STUDY
Po. Daily et al., EFFECT OF PROPHYLACTIC EPSILON-AMINOCAPROIC ACID ON BLOOD-LOSS AND TRANSFUSION REQUIREMENTS IN PATIENTS UNDERGOING FIRST-TIME CORONARY-ARTERY BYPASS-GRAFTING - A RANDOMIZED, PROSPECTIVE, DOUBLE-BLIND-STUDY, Journal of thoracic and cardiovascular surgery, 108(1), 1994, pp. 99-108
The prophylactic use of aprotinin has recently been reported to be ass
ociated with a significant decrease in blood loss in patients undergoi
ng cardiopulmonary bypass: procedures. One of the primary effects of a
protinin is prevention of plasmin degradation of platelet function. Be
cause aprotinin is commercially unavailable in the United States at th
is time, we evaluated epsilon-aminocaproic acid with respect to decrea
sed perioperative blood loss. We prospectively randomized 40 patients
undergoing first-time coronary artery bypass grafting without prior st
ernotomy into two groups: one group (n = 21) received prophylactic and
preincision epsilon-aminocaproic acid and the other (n = 19) received
a placebo. No significant differences existed between patient groups
with respect to age, body surface area, cardiopulmonary bypass time, a
nd aortic crossclamp time. Cumulative blood loss at 4, 8, 12, and 24 h
ours after chest closure was significantly less in the epsilon-aminoca
proic acid group (426 +/- 242 ml versus 634 +/- 224 ml, p = 0.002, at
12 hours). Only one patient receiving epsilon-aminocaproic acid was gi
ven blood or blood components compared to five patients in the placebo
group (p < 0.02). D-dimers and fibrin split products were significant
ly less prevalent in the epsilon-aminocaproic acid group (at 4 hours:
0/20 versus 7/16, p < 0.002 and 5/20 versus 12/19, p < 0.05, respectiv
ely). None of the patients had a perioperative myocardial infarction o
r cerebrovascular accident. The prophylactic administration of epsilon
-aminocaproic acid results in a significant decrease in blood loss in
patients undergoing first-time coronary artery bypass grafting, and bl
ood transfusion requirements are significantly less. It may be importa
nt to administer epsilon-aminocaproic acid before skin incision to be
optimally effective.